With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
The FDA has approved a breathalyzer about the size of a carry-on suitcase to instantly detect COVID-19 in healthcare settings after a prospective study of 2409 patients demonstrated a sensitivity of 91% and specificity of 99%. | FDA 2022
Comments
Post a Comment